Related Experiment Videos

Diabetes and dyslipidaemia

Sherwyn L Schwartz1

  • 1Diabetes and Glandular Disease Clinic, San Antonio, TX 78229-4801, USA.

Diabetes, Obesity & Metabolism
|June 17, 2006
PubMed

Insights

Diabetic dyslipidaemia increases cardiovascular disease (CVD) risk. Managing it involves lifestyle changes, improved glycemic control, and lipid-lowering therapy when needed to reach target cholesterol levels.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Disorders

Background:

  • Diabetic individuals face higher cardiovascular disease (CVD) risks and poorer prognoses compared to non-diabetics.
  • Diabetic dyslipidaemia presents as hypertriglyceridaemia, low high-density lipoprotein cholesterol (HDL-C), and small, dense low-density lipoprotein (LDL) particles.

Purpose of the Study:

  • To outline the management strategies for diabetic dyslipidaemia.
  • To define targets and initiation criteria for lipid-lowering therapy in diabetic patients.

Main Methods:

  • Lifestyle modifications including increased physical activity and weight loss.
  • Pharmacological interventions such as cholesterol-lowering drugs, oral hypoglycaemic agents, and insulin therapy.
  • Monitoring of glycemic control and lipid levels (LDL-C, non-HDL-C, triglycerides).

Main Results:

  • Lifestyle changes and improved glycemic control are primary management steps.
  • Lipid-lowering therapy is indicated if LDL-C remains above 100 mg/dl or triglycerides are >=150 mg/dl despite lifestyle and glycemic control efforts.
  • Intensive insulin therapy can achieve tight glycemic control and reduce triglyceride levels.

Conclusions:

  • Effective management of diabetic dyslipidaemia requires a multi-faceted approach.
  • Achieving target lipid levels is crucial for reducing CVD risk in diabetic patients.
  • Glycemic control is a priority and directly impacts lipid profiles, particularly triglycerides.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...